CEACAM5 and gastric cancer: The signatures including T stage, N stage, lymphatic/vascular/nerve infiltration, CEA and CA19-9 based on nomogram scales could distinguish the prognosis of stage I-III GC patients with different risk scores accurately and have broad clinical application prospects.